The new T.N. syllabus for Classes 1-5 emphasizes skill development through engaging activities while integrating foundational literacy and numeracy.

Entering Year 4, Sanders owns a 16-19 record, is coming off a 3-9 season and earns $10 million annually. He says this team ...

WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...

Epiccarry publishes authoritative industry reports and in-depth analyses on MMORPG design, player retention, and long-term ...

During the opening session, the CEO unveiled Alba’s Objectives for 2026: Safety 5 Star, Think Global, e-F Al Hassalah, and ...

After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco ...

From City Hall and state government to tech, transit and the arts, these figures are poised to shape Austin's year ahead.

Navan's Kim Hamer talks about what travel buyers say they need now, why the end-to-end experience matters, performance of AI agent support, market volatility and resulting opportunities.

Inflation-linked cash flows and a capex supercycle suggest listed infrastructure remains mispriced as growth improves.

Preliminary Unaudited Fourth Quarter and Full Year 2025 Results Core revenue in the fourth quarter is expected to be between $6.6 million and $6.7 million. Core revenue for the full year is expected ...

Detailed price information for Allogene Therapeutics Inc (ALLO-Q) from The Globe and Mail including charting and trades.

Lantern Pharma Inc. , a pioneer in AI-driven precision oncology and computational therapeutic development, today announced the establishment of an A.I. Center of Excellence and Advanced Agentic Labs ...